Age-related increases in IGFBP2 increase melanoma cell invasion and lipid synthesis
Preprint
Abstract
Aged melanoma patients (>65 years old) have more aggressive disease relative to young patients (5-fold levels of insulin-like growth factor binding protein 2 (IGFBP2) in the aged fibroblast secretome. IGFBP2 functionally triggers upregulation of the PI3K-dependent fatty acid biosynthesis program in melanoma cells through increases in FASN. Melanoma cells co-cultured with aged dermal fibroblasts have higher levels of lipids relative to young dermal fibroblasts, which can be lowered by silencing IGFBP2 expression in fibroblasts, prior to treating with conditioned media. Conversely, ectopically treating melanoma cells with recombinant IGFBP2 in the presence of conditioned media from young fibroblasts, promoted lipid synthesis and accumulation in the melanoma cells. Neutralizing IGFBP2 in vitro reduces migration and invasion in melanoma cells, and in vivo studies demonstrate that neutralizing IGFBP2 in syngeneic aged mice, ablates tumor growth as well as metastasis. Conversely, ectopic treatment of young mice with IGFBP2 in young mice increases tumor growth and metastasis. Our data reveal that aged dermal fibroblasts increase melanoma cell aggressiveness through increased secretion of IGFBP2, stressing the importance of considering age when designing studies and treatment. Significance: The aged microenvironment drives metastasis in melanoma cells. This study reports that IGFBP2 secretion by aged fibroblasts induces FASN in melanoma cells and drives metastasis. Neutralizing IGFBP2 decreases melanoma tumor growth and metastasis.Keywords
All Related Versions
- Published version: Cancer Research Communications, 4 (8), 1908.
This publication has 47 references indexed in Scilit:
- Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour developmentDisease Models & Mechanisms, 2013
- The Hallmarks of AgingCell, 2013
- Sterol regulatory element binding protein-dependent regulation of lipid synthesis supports cell survival and tumor growthCancer & Metabolism, 2013
- The Three-Dimensional Human Skin Reconstruct Model: a Tool to Study Normal Skin and Melanoma ProgressionJournal of Visualized Experiments, 2011
- Insulin-like growth factor-binding protein-2 promotes prostate cancer cell growth via IGF-dependent or -independent mechanisms and reduces the efficacy of docetaxelBritish Journal of Cancer, 2011
- Senescent cells as a source of inflammatory factors for tumor progressionCancer and Metastasis Reviews, 2010
- Expression of Fatty Acid Synthase Depends on NAC1 and Is Associated with Recurrent Ovarian Serous CarcinomasJournal of Oncology, 2010
- Antidiabetic Effects of IGFBP2, a Leptin-Regulated GeneCell Metabolism, 2010
- Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K/Akt pathway activation in glioblastoma and prostate cancerProceedings of the National Academy of Sciences, 2007
- Role of the Insulin-Like Growth Factor Family in Cancer Development and ProgressionJNCI: Journal of the National Cancer Institute, 2000